Overview
A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.
Indication
It is used as a solvent, emollient, pharmaceutical agent, and sweetening agent.
Associated Conditions
- Cold Sore
- Constipation
- Dry Mouth
- Dry Skin
- Dry throat
- Edema of the cerebrum
- Increase in Intracranial Pressure (ICP)
- Occasional Constipation
- Ocular Discomfort
- Ocular Hypertension
- Ocular Irritation
- Skin Infections
- Sore Throat
- Mouth soreness
- Sensation of burning in the eyes
Research Report
A Comprehensive Monograph on Glycerin (Glycerol): Pharmacology, Clinical Applications, and Safety Profile
1.0 Introduction and Chemical Identity
1.1 Overview of Glycerin as a Polyol Compound
Glycerin, also known as glycerol, is a simple polyol compound that holds a position of fundamental importance in both biological systems and industrial processes. Structurally, it is a trihydroxy sugar alcohol, or triol, and serves as a critical intermediate in the metabolism of carbohydrates and lipids.[1] It is a naturally occurring substance, forming the structural backbone of all lipids known as glycerides.[2] In its pure form, glycerin is a clear, colorless, odorless, and viscous liquid characterized by a distinctly sweet taste.[2] These unique physicochemical properties, particularly its strong affinity for water, have led to its ubiquitous use across a vast spectrum of applications. It is a cornerstone ingredient in pharmaceutical formulations, a staple in the cosmetics and personal care industries, a versatile additive in food manufacturing, and a valuable component in numerous industrial applications.[3] Its versatility is such that it can function as an active pharmaceutical ingredient, a pharmaceutical excipient, a food additive, and an industrial chemical, making a comprehensive understanding of its properties and actions essential for a wide range of scientific and clinical disciplines.
1.2 Nomenclature and Identification
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/05/02 | Phase 1 | Not yet recruiting | |||
2025/03/25 | Phase 4 | Completed | VZW Cardiovascular Research Center Aalst | ||
2025/03/20 | Phase 2 | Not yet recruiting | |||
2024/07/09 | Phase 4 | Completed | Aswan University Hospital | ||
2023/09/21 | Not Applicable | Recruiting | KK Women's and Children's Hospital | ||
2023/04/20 | Phase 4 | Recruiting | |||
2022/12/21 | Phase 2 | Active, not recruiting | Wills Eye | ||
2022/12/21 | Not Applicable | Completed | |||
2022/08/11 | Phase 1 | Withdrawn | |||
2021/08/24 | Phase 2 | UNKNOWN | Kaplan Medical Center |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Antigen Laboratories, Inc. | 49288-9932 | INTRADERMAL, SUBCUTANEOUS | 0.1 mL in 1 mL | 12/8/2009 | |
| Army and Air Force Exchange Service | 55301-998 | OPHTHALMIC | 0.5 g in 100 mL | 1/1/2024 | |
| Antigen Laboratories, Inc. | 49288-9936 | INTRADERMAL, SUBCUTANEOUS | 0.25 mL in 1 mL | 12/8/2009 | |
| Harris Teeter, LLC. | 69256-979 | OPHTHALMIC | 0.25 g in 100 mL | 1/1/2024 | |
| OASIS Medical, Inc. | 42126-6400 | OPHTHALMIC | 0.25 g in 100 mL | 9/12/2025 | |
| Antigen Laboratories, Inc. | 49288-9935 | INTRADERMAL, SUBCUTANEOUS | 0.5 mL in 1 mL | 12/8/2009 | |
| Rising Pharma Holdings, Inc. | 57237-325 | RECTAL | 2 g in 1 1 | 9/8/2025 | |
| Optiq Eyecare LLC | 85949-112 | OPHTHALMIC | 9 mg in 1 mL | 9/20/2025 | |
| CVS Pharmacy | 59779-109 | RECTAL | 2 g in 1 1 | 7/13/2025 | |
| Shanghai Yijing Medical Technology Co., Ltd. | 85157-002 | RECTAL | 7.2 g in 10 mL | 2/19/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| GLYCEROL 2G SUPPOSITORIES FOR CHILDREN | SIN02823P | SUPPOSITORY | 1.4 g | 5/22/1989 | |
| MINICA S ENEMA | SIN03514P | ENEMA | 12.5% w/w | 6/15/1989 | |
| HUACHI ENEMA | SIN02959P | ENEMA | 6 g/20 ml | 5/26/1989 | |
| LEMON SWEET PURGATIVE SYRUP | SIN02748P | SYRUP | 1.1% | 5/9/1989 | |
| KABIVEN EMULSION FOR INFUSION | SIN11657P | INJECTION | 4.3 g/1000 ml | 9/4/2001 | |
| LIPOFUNDIN MCT/LCT INFUSION 20% | SIN05658P | INJECTION | 25 g/1000 ml | 4/8/1991 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| GVSOFT ADULT SUPPOSITORIES 70% W/W | N/A | N/A | N/A | 1/15/2025 | |
| GVSOFT CHILD SUPPOSITORIES 70% W/W | N/A | N/A | N/A | 1/15/2025 | |
| SHUN BINLING ENEMA | N/A | N/A | N/A | 3/16/2012 | |
| LUBRICARE ENEMA 43% W/V | N/A | N/A | N/A | 6/3/2020 | |
| PERSTON ENEMA | N/A | N/A | N/A | 4/26/2001 | |
| CLYSTER JEN SHENG ENEMA | N/A | N/A | N/A | 6/24/1997 | |
| QUIKCECOL ENEMA 43% W/V | N/A | N/A | N/A | 6/3/2020 |
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| ORAPLEX COLD SORE GEL | 39772 | Medicine | A | 4/27/1992 | |
| QV DERMCARE ECZEMA FLARE UP CREAM | 387944 | Medicine | A | 5/4/2022 | |
| EGO EMOLLIENT cream tube | 10629 | Medicine | A | 8/2/1991 | |
| EGO EMOLLIENT cream jar | 11618 | Medicine | A | 8/2/1991 | |
| PHARMACY SELECT BABY TEETHING GEL tube | 39770 | Medicine | A | 4/27/1992 | |
| PETRUS GLYCEROL 1.4g SUPPOSITORIES FOR CHILDREN strip pack | 12788 | Medicine | A | 8/28/1991 | |
| Kenkay Dry Skin Body Wash | 323609 | Medicine | A | 9/16/2019 | |
| KenKay Extra Relief Hand Balm | 374989 | Medicine | A | 9/21/2021 | |
| Magnoplasm Paste | 29623 | Medicine | A | 10/25/1991 | |
| Resurge Recovery Performance Moisturiser | 449225 | Medicine | A | 5/21/2024 |
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| GLY-RECTAL SUP POUR ENFANTS | lab valmo enregistré, division of technilab inc. | N/A | Suppository - Rectal | 91 % / SUP | 12/31/1979 |
| VISINE CONTACT LENS | johnson & johnson inc | 02229483 | Drops - Ophthalmic | 0.2 % | 8/24/1998 |
| CLEAR EYES EXTRA STRENGTH REDNESS RELIEF | prestige brands inc | 02360837 | Solution - Ophthalmic | 0.50 % / W/V | 4/27/2011 |
| LUBRICANT EYE DROPS | kc pharmaceuticals inc | 02455579 | Solution - Ophthalmic | 0.2 % / W/V | N/A |
| DRY EYE TEARS | juno otc inc | 02389886 | Solution - Ophthalmic | 0.2 % / W/V | 2/12/2014 |
| OPTREX EYE DROPS | schering-plough healthcare products canada, a division of schering canada inc. | 02236576 | Drops - Ophthalmic | 1 % | 8/20/1998 |
| THERAPEUTIC HAND CREAM | e.t. browne drug co., inc. | 02253399 | Cream - Topical | 27.6 % | N/A |
| OPTREX EYE DROPS | knoll pharma inc. | 02185482 | Drops - Ophthalmic | 1 % | 12/31/1996 |
| GLYCERINUM-INJEEL LIQ (10D,30D,200D/1.1ML) | 02058324 | Liquid - Oral | 10 D / 1.1 ML | 12/31/1993 | |
| REFRESH OPTIVE FUSION SENSITIVE | 02450534 | Solution - Ophthalmic | 1 % / W/V | 4/26/2016 |
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.
